ARVN – arvinas, inc. (US:NASDAQ)
Stock Stats
News
Arvinas (ARVN) had its price target raised by Citigroup Inc. from $15.00 to $18.00. They now have a "buy" rating on the stock.
Arvinas Highlights Growing Phase 1 Pipeline, Near-Term Catalysts at TD Cowen Healthcare Conference [Yahoo! Finance]
Prostate Cancer Market Competitive Landscape Report 2026: Comprehensive Insights About 230+ Companies and 265+ Drugs by Product Type, Stage, and Route of Administration [Yahoo! Finance]
Arvinas, Inc. (ARVN) Makes Significant Progress on Oncology and Neurology Trials [Yahoo! Finance]
Arvinas (ARVN) was downgraded by Wall Street Zen from "hold" to "sell
Form 4 ARVINAS, INC. For: Feb 26 Filed by: Loomis David K
Form 4 ARVINAS, INC. For: Feb 26 Filed by: Berkowitz Noah
Form 4 ARVINAS, INC. For: Feb 26 Filed by: Cacace Angela M
Form 4 ARVINAS, INC. For: Feb 26 Filed by: Saik Andrew
Form 4 ARVINAS, INC. For: Feb 26 Filed by: Teel Randy
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.